Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients

Intensive Care Medicine

Volumn 35, Issue 7, 2009, Pages 1271-1275

  Kirwan, Christopher John ^a   Lee, Terry ^a   Holt, David W ^a   Grounds, R Michael ^a   MacPhee, Iain A M ^a   Philips, Barbara J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acute kidney injury; Midazolam metabolism

Indexed keywords

MIDAZOLAM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG METABOLISM; FEMALE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; LIVER METABOLISM; MALE; MEASUREMENT; METABOLIC DISORDER; RELIABILITY;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CRITICAL ILLNESS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; KIDNEY FAILURE, ACUTE; LIVER; MALE; MIDAZOLAM; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 67649360564     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1430-7     Document Type: Article

References (15)

1. A Paulussen K Lavrijsen H Bohets J Hendrickx P Verhasselt W Luyten F Konings M Armstrong 2000 Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans Pharmacogenetics 10 415 424 (Pubitemid 30433575)
2. FP Guengerich 1999 Cytochrome P-450 3A4: regulation and role in drug metabolism Annu Rev Pharmacol Toxicol 39 1 17 (Pubitemid 29222549)
3. YS Lin GF Lockwood MA Graham WR Brian CM Loi MR Dobrinska DD Shen PB Watkins GR Wilkinson ED Kharasch KE Thummel 2001 In vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration Pharmacogenetics 11 781 791 (Pubitemid 33151513)
4. JC Gorski SD Hall DR Jones M VandenBranden SA Wrighton 1994 Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily Biochem Pharmacol 47 1643 1653 (Pubitemid 24167278)
5. MD Floyd G Gervasini AL Masica G Mayo AL George Jr K Bhat RB Kim GR Wilkinson 2003 Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women Pharmacogenetics 13 595 606 (Pubitemid 37311146)
6. KE Thummel DD Shen TD Podoll KL Kunze WF Trager PS Hartwell VA Raisys CL Marsh JP McVicar DM Barr 1994 Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients J Pharmacol Exp Ther 271 549 556 (Pubitemid 24333173)
7. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470
8. R Bellomo J Kellum C Ronco 2001 Acute renal failure: time for consensus Intensive Care Med 27 1685 1688 (Pubitemid 33139827)
9. C Wandel JS Witte JM Hall CM Stein AJ Wood GR Wilkinson 2000 CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5≥-promoter region polymorphism Clin Pharmacol Ther 68 82 91 (Pubitemid 30609830)
10. CL Zimmerman JT Slattery 1983 Maintenance-dose prediction based on a single determination of concentration: general applicability to two-compartment drugs with reference to lithium J Pharm Sci 72 1262 1266
11. SE Ball J Scatina J Kao GM Ferron R Fruncillo P Mayer I Weinryb M Guida PJ Hopkins N Warner J Hall 1999 Population distribution and effects on drug metabolism of a genetic variant in the 5≥ promoter region of CYP3A4 Clin Pharmacol Ther 66 288 294 (Pubitemid 29451761)
12. YS Lin AL Dowling SD Quigley FM Farin J Zhang J Lamba EG Schuetz KE Thummel 2002 Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism Mol Pharmacol 62 162 172 (Pubitemid 34680528)
13. P Kuehl J Zhang Y Lin J Lamba M Assem J Schuetz PB Watkins A Daly SA Wrighton SD Hall P Maurel M Relling C Brimer K Yasuda R Venkataramanan S Strom K Thummel MS Boguski E Schuetz 2001 Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Nat Genet 27 383 391 (Pubitemid 32268418)
14. C Guevin J Michaud J Naud FA Leblond V Pichette 2002 Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators Br J Pharmacol 137 1039 1046 (Pubitemid 35440744)
15. J Michaud P Dube J Naud FA Leblond K Desbiens A Bonnardeaux V Pichette 2005 Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450 Br J Pharmacol 144 1067 1077 (Pubitemid 40593005)